Author Correction: The real-world selection of first-line systemic therapy regimen for metastatic gastroenteropancreatic neuroendocrine neoplasm in Japan

• Shun Yamamoto,
• Naoki Sakakibara,
• Hidekazu Hirano,
• Chigusa Morizane,
• Yoshitaka Honma,
• Susumu Hijioka,
• Takuji Okusaka,
• Takahiro Higashi,
• Akira Kawai

Affiliations

Shun Yamamoto

Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital

Naoki Sakakibara

Division of Health Services Research, Institute for Cancer Control, National Cancer Center

Hidekazu Hirano

Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital

Chigusa Morizane

Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital

Yoshitaka Honma

Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital

Susumu Hijioka

Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital

Takuji Okusaka

Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital

Takahiro Higashi

Division of Health Services Research, Institute for Cancer Control, National Cancer Center

Akira Kawai

Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital